Tri-nasal triamcinolone acetonide nasal spray 200 and 400 μg qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 μg qd in patients suffering from seasonal allergic rhinitis during the grass season

R. Rosenthal, W. Berger, E. Bronsky, R. Dockhorn, P. Korenblat, K. Lampl, W. Lumry, S. Pollard, G. Raphael, C. Rohr, G. Shapiro, M. Valentine, A. Wanderer, L. Fleming, N. Lavallee, M. Stepanians, J. Karafilidis, J. Shilstone, Elliot Ellis

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Tri-nasal triamcinolone acetonide nasal spray 200 and 400 μg qd versus placebo and nasacort triamcinolone acetonide nasal aerosol 440 μg qd in patients suffering from seasonal allergic rhinitis during the grass season'. Together they form a unique fingerprint.

Medicine & Life Sciences